These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25172987)

  • 61. Rat model of reperfused partial liver infarction: characterization with multiparametric magnetic resonance imaging, microangiography, and histomorphology.
    Wu X; Wang H; Chen F; Jin L; Li J; Feng Y; DeKeyzer F; Yu J; Marchal G; Ni Y
    Acta Radiol; 2009 Apr; 50(3):276-87. PubMed ID: 19160078
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Silent T
    Schulte RF; Buonincontri G; Costagli M; Menini A; Wiesinger F; Solana AB
    Magn Reson Med; 2019 Apr; 81(4):2277-2287. PubMed ID: 30387897
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T.
    Ingrisch M; Sourbron S; Morhard D; Ertl-Wagner B; Kümpfel T; Hohlfeld R; Reiser M; Glaser C
    Invest Radiol; 2012 Apr; 47(4):252-8. PubMed ID: 22373532
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of quantitative dynamic susceptibility-contrast MRI perfusion estimates obtained using different contrast-agent administration schemes at 3T.
    Wirestam R; Thilmann O; Knutsson L; Björkman-Burtscher IM; Larsson EM; Ståhlberg F
    Eur J Radiol; 2010 Jul; 75(1):e86-91. PubMed ID: 19720489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
    Bell LC; Stokes AM; Quarles CC
    J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Slice accelerated gradient-echo spin-echo dynamic susceptibility contrast imaging with blipped CAIPI for increased slice coverage.
    Eichner C; Jafari-Khouzani K; Cauley S; Bhat H; Polaskova P; Andronesi OC; Rapalino O; Turner R; Wald LL; Stufflebeam S; Setsompop K
    Magn Reson Med; 2014 Sep; 72(3):770-8. PubMed ID: 24285593
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Classic models for dynamic contrast-enhanced MRI.
    Sourbron SP; Buckley DL
    NMR Biomed; 2013 Aug; 26(8):1004-27. PubMed ID: 23674304
    [TBL] [Abstract][Full Text] [Related]  

  • 69. T2-prepared segmented 3D-gradient-echo for fast T2-weighted high-resolution three-dimensional imaging of the carotid artery wall at 3T: a feasibility study.
    Zhu J; Bornstedt A; Merkle N; Liu N; Rottbauer W; Ma G; Rasche V
    Biomed Eng Online; 2016 Dec; 15(Suppl 2):165. PubMed ID: 28155713
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Gadolinium-Enhanced Susceptibility-Weighted Imaging in Multiple Sclerosis: Optimizing the Recognition of Active Plaques for Different MR Imaging Sequences.
    do Amaral LLF; Fragoso DC; Nunes RH; Littig IA; da Rocha AJ
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):614-619. PubMed ID: 30846435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Contrast agent dose effects in cerebral dynamic susceptibility contrast magnetic resonance perfusion imaging.
    Alger JR; Schaewe TJ; Lai TC; Frew AJ; Vespa PM; Etchepare M; Liebeskind DS; Saver JL; Kidwell SC
    J Magn Reson Imaging; 2009 Jan; 29(1):52-64. PubMed ID: 19097106
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of ferumoxytol-based cerebral blood volume estimates using quantitative R
    Rivera-Rivera LA; Schubert T; Knobloch G; Turski PA; Wieben O; Reeder SB; Johnson KM
    Magn Reson Med; 2018 Jun; 79(6):3072-3081. PubMed ID: 29096054
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques.
    Speck O; Chang L; DeSilva NM; Ernst T
    J Magn Reson Imaging; 2000 Sep; 12(3):381-7. PubMed ID: 10992304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dual-contrast pCASL using simultaneous gradient-echo/spin-echo multiband EPI.
    Zhang K; Sturm VJ; Buschle LR; Hahn A; Yun SD; Jon Shah N; Bendszus M; Heiland S; Schlemmer HP; Ziener CH; Kurz FT
    Magn Reson Imaging; 2019 Apr; 57():359-367. PubMed ID: 30500347
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessment of cerebrovascular reactivity by dynamic susceptibility contrast-enhanced MR imaging.
    Nighoghossian N; Berthezene Y; Meyer R; Cinotti L; Adeleine P; Philippon B; Froment JC; Trouillas P
    J Neurol Sci; 1997 Aug; 149(2):171-6. PubMed ID: 9171326
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Technical considerations on the validity of blood oxygenation level-dependent-based MR assessment of vascular deoxygenation.
    Hirsch NM; Toth V; Förschler A; Kooijman H; Zimmer C; Preibisch C
    NMR Biomed; 2014 Jul; 27(7):853-62. PubMed ID: 24809665
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Noninvasive functional imaging of cerebral blood volume with vascular-space-occupancy (VASO) MRI.
    Lu H; Hua J; van Zijl PC
    NMR Biomed; 2013 Aug; 26(8):932-48. PubMed ID: 23355392
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Whole brain quantitative CBF, CBV, and MTT measurements using MRI bolus tracking: implementation and application to data acquired from hyperacute stroke patients.
    Smith AM; Grandin CB; Duprez T; Mataigne F; Cosnard G
    J Magn Reson Imaging; 2000 Sep; 12(3):400-10. PubMed ID: 10992307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.